[A-DERMATODAYS - Replays] - ATOPIC DERMATITIS : An immersion in the night of a patient
On November 07 and 08, 2024, A-DERMA organized the A-DERMATODAYS at Terre d'Avoine. For the first time, this innovative scientific and medical event brought together some twenty international experts, including dermatologists, scientists and in-house experts, to decode advances in the management of atopic dermatitis and pruritus.
During these 2 days, we deepened our understanding of Atopic Dermatitis, focusing on nocturnal pruritus, a particularly disabling symptom for patients.
We were honored to welcome three internationally renowned "Key Opinion Leaders " to present their expertise: Prof. Jacek C. Szepietowski (Poland), Prof. Christian Vestergaard (Denmark), Dr. Chris Callewaert, (Belgium) as well as Fabrice Lestienne (R&D Expert, Pierre Fabre) and the Eczema Foundation.
What you'll discover in the replays:
- The latest advances in understanding the pathophysiology of pruritus in atopic dermatitis, as well as groundbreaking information on nocturnal pruritus that could transform your approach to treatment.
- The profound impact of pruritus on patients' quality of life, including its effects on sleep, obesity, anxiety and depression, and learn how to effectively assess this quality of life to improve your patients' well-being.
- Breakthrough innovations in dermo-cosmetics with a new active ingredient, helichrysum, which targets the JAK pathway and is inspired by the latest AD treatments. Discover also its role in stimulating neurite growth and inhibiting IL-31.
- The demonstration of a strong link between the microbiome, TH2 inflammation and the severity of atopic dermatitis, opening the way to new therapeutic perspectives.
Part 1 - Itch: the central symptom of atopic dermatitis and its impact on daily comfort
20 min
Part 2 - Decoding the science of nighttime itch in atopic dermatitis
18 min
Part 3 - Microbiome in atopic dermatitis: from etiology to future therapies
18 min
Part 4 - Botanical extracts' synergy on atopic dermatitis via TH2 pathway
15 min
Part 5 - "ECZEMA CARE+" Apps
30 min.
Interested in our news?
Discover those of our other brands.
Want to read on?
This access is reserved for professionals, registered on Pierre Fabre For Med.
To access the full content, please register or log in if you already have an account.